Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Alterity Therapeutics
(NASDAQ:ATHE)
Intraday
$2.2916
0.1616
[7.59%]
After-Hours
$2.2916
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$2.2916
0.1616
[7.59%]
At close: Apr 24
$2.2916
0
[0.00%]
After Hours: 7:13PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Alterity Therapeutics Stock (NASDAQ:ATHE)
Alterity Therapeutics Stock (NASDAQ: ATHE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 24, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
8 hours ago
Tuesday, April 23, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
1 day ago
Wednesday, April 17, 2024
Alterity Therapeutics Parkinson's Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
Benzinga Newsdesk
-
Apr 17, 2024, 7:26AM
Monday, April 15, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Apr 15, 2024, 4:31PM
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Apr 15, 2024, 2:11PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Apr 15, 2024, 12:31PM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Apr 15, 2024, 8:07AM
Thursday, March 07, 2024
Benchmark Reiterates Speculative Buy on Alterity Therapeutics, Maintains $4 Price Target
Benzinga Newsdesk
-
Mar 7, 2024, 8:43AM
Thursday, February 22, 2024
Alterity Therapeutics Earlier Announced A Proposed Offering Of 285,087,720 Shares
Charles Gross
-
Feb 22, 2024, 8:19PM
Trading Halt: Halt status updated at 6:55:00 PM ET: Quotation Resumption: News and Resumption Times
Benzinga Newsdesk
-
Feb 22, 2024, 6:55PM
Wednesday, February 21, 2024
Alterity Therapeutics Shares Halted; Co Requested That Its Securities Be Placed Into An Immediate Trading Halt Pending An Announcement In Relation To A Capital Raise
Charles Gross
-
Feb 21, 2024, 5:43PM
Trading Halt: Halted at 5:41:10 p.m. ET - Trading Halt: Halt News Pending
Benzinga Newsdesk
-
Feb 21, 2024, 5:41PM
Tuesday, February 06, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Feb 6, 2024, 8:06AM
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review
Benzinga Newsdesk
-
Feb 6, 2024, 7:26AM
Monday, January 22, 2024
Alterity Therapeutics Highlights Successes in MSA Research and Plans for Parkinson's Disease Trials in Shareholder Letter
Benzinga Newsdesk
-
Jan 22, 2024, 7:29AM
Monday, January 15, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Jan 15, 2024, 4:30PM
Thursday, December 21, 2023
Alterity Therapeutics Names Phillip Hains As New Chief Financial Officer, Effective January 31, 2024
Benzinga Newsdesk
-
Dec 21, 2023, 1:22AM
Tuesday, December 05, 2023
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Dec 5, 2023, 1:06PM
Why GitLab Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Dec 5, 2023, 9:04AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Dec 5, 2023, 8:07AM
Monday, December 04, 2023
Alterity Therapeutics To Host Webcast To Discuss ATH434 Efficacy Data In Primates And Recent Clinical Progress
Benzinga Newsdesk
-
Dec 4, 2023, 4:35PM
Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Dec 4, 2023, 1:10PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Dec 4, 2023, 12:31PM
Alterity Therapeutics shares are trading higher after the company announced efficacy data for ATH434 in a primate model of Parkinson's disease.
Benzinga Newsdesk
-
Dec 4, 2023, 11:17AM
Nasdaq Down Over 100 Points; Alaska Air To Acquire Hawaiian Airlines
Lisa Levin
-
Dec 4, 2023, 9:58AM
Why Is Neurodegenerative Disease-Focused Alterity Therapeutics Stock Trading Over 200% Higher Today?
Vandana Singh
-
Dec 4, 2023, 9:11AM
Market-Moving News for December 4th
Benzinga Newsdesk
-
Dec 4, 2023, 8:48AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Dec 4, 2023, 8:06AM
Alterity Therapeutics Presents New Data On Effect Of ATH434 In Parkinson's Disease Primate Model; Says ATH434 Improved Motor Performance And General Function
Benzinga Newsdesk
-
Dec 4, 2023, 7:27AM
Alterity Therapeutics Announced Sunday, Efficacy Data for ATH434 In A Primate Model Of Parkinson's Disease; Said ATH434 Improved Motor Performance And General Function
Charles Gross
-
Dec 4, 2023, 4:54AM
Monday, November 27, 2023
Alterity Therapeutics Earlier Announced Presentation Of Novel Biomarker Data For Evaluation Of Multiple System Atrophy
Charles Gross
-
Nov 27, 2023, 5:17AM
Thursday, November 23, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Nov 23, 2023, 12:30PM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Nov 23, 2023, 8:05AM
Wednesday, November 22, 2023
Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Nov 22, 2023, 2:03PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Nov 22, 2023, 12:31PM
Dow Surges 150 Points; US Jobless Claims Decline Sharply
Lisa Levin
-
Nov 22, 2023, 9:43AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Nov 22, 2023, 8:06AM
Why Guess? Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Nov 22, 2023, 7:58AM
Monday, November 20, 2023
Alterity Therapeutics Shares Halted, Pending News. Co Reported Sunday It Would Make An Announcement Regarding A Capital Raise
Charles Gross
-
Nov 20, 2023, 6:36AM
Thursday, November 16, 2023
Alterity Therapeutics Announced New Data Related To ATH434 Was Presented At The Society For Neuroscience
Benzinga Newsdesk
-
Nov 16, 2023, 7:26AM
Wednesday, November 15, 2023
Alterity Therapeutics Announced Presentation of New Data Demonstrating Novel Mechanisms of ATH434
Charles Gross
-
Nov 15, 2023, 5:46PM
Wednesday, November 08, 2023
Alterity Therapeutics Completes Enrollment In ATH434-201 Phase 2 Clinical Trial In Multiple System Atrophy
Benzinga Newsdesk
-
Nov 8, 2023, 7:37AM
Alterity Therapeutics Completes Enrolment in ATH434-201 Phase 2 Clinical Trial in Multiple System Atrophy
Charles Gross
-
Nov 8, 2023, 6:26AM
Monday, October 30, 2023
Alterity Therapeutics Announced Cash balance On September 30, 2023 Of A$16.7M
Charles Gross
-
Oct 30, 2023, 7:29AM
Monday, October 02, 2023
Alterity Therapeutics Ltd Files For Mixed Shelf Of Up To $50M
Benzinga Newsdesk
-
Oct 2, 2023, 11:48AM
Thursday, August 31, 2023
Alterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder, At The International Congress Of Parkinson's Disease And Movement Disorders
Benzinga Newsdesk
-
Aug 31, 2023, 7:30AM
Wednesday, August 23, 2023
Alterity Therapeutics Granted New Composition Of Matter Patent In Europe For Neurodegenerative Diseases including Parkinson's And Alzheimer's
Charles Gross
-
Aug 23, 2023, 4:49AM
Tuesday, August 22, 2023
Alterity Therapeutics Announced That Poster Presentations From Its bioMUSE Natural History Study Of Multiple System Atrophy Will Be Delivered At International Congress Of Parkinson's Disease And Movement Disorders Taking Place August 27-31 In Denmark - 8K
Benzinga Newsdesk
-
Aug 22, 2023, 7:11AM
Tuesday, August 15, 2023
Alterity Therapeutics Announced Late Tuesday It Received A A$4.74M Research & Development Tax Incentive Refund
Charles Gross
-
Aug 15, 2023, 4:54AM
Monday, July 31, 2023
Alterity Therapeutics Announced Earlier It Had A Cash Balance On June 30, 2023 Of A$15.8M
Charles Gross
-
Jul 31, 2023, 4:52AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch